Oct 23rd, 2024
Late-Breaking Science for Sunday
Two presentations feature results from intervention and prevention studies.
Late-Breaking Science | LBS.04 | From Intervention to Prevention: Advances in Coronary and Valvular Heart Disease
Sunday, Nov. 17 | 8:00–9:15 a.m. | Main Event I
Interventional Treatments
- Efficacy of Restrictive vs. Liberal Oxygenation in Patients Undergoing Coronary Artery Bypass Grafting or Aortic Valve Replacement: A Randomized Clinical Trial (GLORIOUS)
- Efficacy of a Glucagon-Like Peptide-1 Agonist in Patients Undergoing Coronary Artery Bypass Grafting or Aortic Valve Replacement: A Randomized Clinical Trial (GLORIOUS)
- Efficacy and Safety of Edoxaban in Anticoagulant Therapy Early After Surgical Bioprosthetic Valve Replacement: ENBALV Trial
- The CLEAR SYNERGY (OASIS 9) Trial: A 2x2 Factorial Randomized Controlled Trial of Colchicine vs. Placebo and Spironolactone vs. Placebo in Patients With Myocardial Infarction: The Results of the Spironolactone Factorial
Late-Breaking Science | LBS.05 | Innovation in Prevention and Global Implementation
Sunday, Nov. 17 | 3:30–4:45 p.m. | Main Event I
Prevention and Lifestyle Medicine
- TOPSPIN- A Three-Arm Randomized Trial for Treatment Optimization of Blood Pressure With Single-Pill Combinations In India
- Electronic Nudges to Increase Influenza Vaccination Among Patients With History of Myocardial Infarction: Insights From 3 Randomized Clinical Trials Enrolling >2 Million Patients (NUDGE-FLU)
- Pragmatic Randomized Controlled Trial of a Decision Support System to Aid Physician Optimization of Early Lipid Lowering Therapies After Acute Coronary Syndrome (ZODIAC)
- Preliminary Results of Randomized Trial of New vs. Reconditioned Pacemakers for Patients Unable to Obtain a New Device in Low- and Middle-Income Countries: The My Heart Your Heart (MHYH) Randomized Trial
